Skip to main content

Table 2 Tumor response after 3 months of combination therapy

From: Bronchial arterial chemoembolization/infusion combined with iodine-125 brachytherapy in advanced non-small cell lung cancer: a promising salvage therapy after standard treatment failure

Variables

Total (n = 45)

The early intervention subgroup (n = 24)

The late intervention subgroup (n = 21)

P

Tumor response, n (%)

Ā Ā Ā 

0.611

ā€ƒCR

3 (6.67)

2 (8.33)

1 (4.76)

Ā 

ā€ƒPR

29 (64.44)

16 (66.67)

13 (61.90)

Ā 

ā€ƒSD

11 (24.44)

6 (25.00)

5 (23.81)

Ā 

ā€ƒPD

2 (4.44)

0 (0.00)

2 (9.52)

Ā 

Assessment indicators

Ā Ā Ā Ā 

ā€ƒORR

32 (71.11)

18 (75.00)

14 (66.67)

0.538

ā€ƒDCR

43 (95.56)

24 (100)

19 (94.48)

0.212

  1. Note: The tumor response was evaluated according to the response evaluation criteria in solid tumors (RECIST 1.1). CR = complete response. PR = partial response. SD = stable disease. PD = progressive disease. ORR = objective response rate=(CR + PR)/TotalƗ100%. DCR = disease control rate =(CR + PR + SD)/TotalƗ100%